fbpx
 

WINDOW ROCK, Ariz. — The Navajo Nation on Tuesday paused the use of the Johnson & Johnson Covid-19 vaccine after the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommendation was announced.

Earlier Tuesday, both federal health agencies recommended the pause in the use of the vaccine based on six reported U.S. cases, out of 6.8 million doses administered nationally, of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. 

“We fully support pausing use of the Johnson & Johnson vaccine on the Navajo Nation until we receive the findings of the investigation. Navajo Area IHS informed us that approximately 4,000 doses of the Johnson & Johnson had been administered on the Navajo Nation,” Navajo Nation President Jonathan Nez said.

Nez said there have been no major side effects reported on the nation’s largest Indian reservation.

“We will continue working with the Navajo Department of Health, Navajo Area IHS, and tribal health facilities to monitor the status of those who received this particular vaccine. Our health care experts indicate that Tuesday’s announcement by the CDC and FDA does not impact the Pfizer and Moderna vaccines,” Nez continued.

According to the CDC, the individuals were all women between the ages of 18 and 48 and symptoms occurred 6 to 13 days after being vaccinated. The events reported are extremely rare and further findings from the CDC and FDA review with Johnson & Johnson is forthcoming. 

According to an IHS statement issued on Tuesday evening, COVID-19 vaccine safety is a top priority for the federal government and is taking all reports of adverse events seriously and has vaccine safety monitoring systems in place. To date, there have been no cases reported through IHS of the rare and severe type of blood clot seen in some individuals who have received the Johnson & Johnson/Janssen vaccine.

As a precaution, if you received the Johnson & Johnson vaccine, and experience severe headache, abdominal pain, leg pain, or shortness of breath within the three weeks after receiving the vaccine, please contact your health provider immediately. People should not be concerned about mild headaches and body aches in the first few days after vaccination. Those are common, temporary side effects brought on by the immune system’s response to the vaccine.

More Stories Like This

The Native Vote: 2022 Survey
Pixel Test
An Update: Indian Boarding Schools
Customer Portal
WATCH: Native Bidaské with Rutherford Falls' Star Jana Schmieding

Do you appreciate a Native perspective on the news? 

For the past decade-plus, we’ve covered the important Indigenous stories that are often overlooked by other media. From the protests at Standing Rock and the toppling of colonizer statues during the racial equity protests, to the ongoing epidemic of Murdered and Missing Indigenous Women (MMIW) and the past-due reckoning related to assimilation, cultural genocide and Indian Boarding Schools, we have been there to provide a Native perspective and elevate Native voices.

Our news is free for everyone to read, but it is not free to produce. That’s why we’re asking you to make a donation this month to help support our efforts. Any contribution — big or small — helps us remain a force for change in Indian Country and continue telling the stories that are so often ignored, erased or overlooked.  Most often, our donors make a one-time gift of $20 or more, while many choose to make a recurring monthly donation of $5 or $10.  Whatever you can do, it helps fund our Indigenous-led newsroom and our ability to cover Native news. 

Donate to Native News Online today and support independent Indigenous journalism. Thank you. 

About The Author
Native News Online Staff
Author: Native News Online StaffEmail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Native News Online is one of the most-read publications covering Indian Country and the news that matters to American Indians, Alaska Natives and other Indigenous people. Reach out to us at [email protected]